Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HPS1 antisense RNA 1 (HPS1-AS1) is a long noncoding RNA (lncRNA) transcribed from the antisense strand at the HPS1 gene locus[5]. Antisense RNAs generally function as regulatory elements that can influence the expression of their corresponding sense genes through a range of mechanisms, including modulation of transcription, mRNA stability, and epigenetic changes[1]. Although many antisense lncRNAs have been implicated in key biological and pathophysiological processes, there is currently no evidence in the primary genomics and biomedical databases that HPS1-AS1 acts as a protein, receptor, enzyme, or other canonical druggable target[5]. There is also no direct implication of HPS1-AS1 in specific pathologies, interacting drug compounds, or roles as a selection or efficacy biomarker. No safety concerns are noted, as there are no reports of direct therapeutic targeting of this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HPS1 antisense RNA 1 (HPS1-AS1).